ASCENDIS PHARMA A/S — Credit Rating and Financial Key Figures

ASCENDIS PHARMA A/S (CVR number: 29918791K) is a company from GENTOFTE. The company reported a net sales of 363.6 mEUR in 2024, demonstrating a growth of 36.3 % compared to the previous year. The operating profit percentage was poor at -76.7 % (EBIT: -278.8 mEUR), while net earnings were -378.1 mEUR. The profitability of the company measured by Return on Assets (ROA) was -24.2 %, which can be considered poor and Return on Equity (ROE) was -37.7 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -8.2 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. ASCENDIS PHARMA A/S's liquidity measured by quick ratio was 0.8 which is at a modest level. Thus, the company's liquid assets are in relative balance with its short-term liabilities, indicating a moderate liquidity position. While it's likely to meet its current obligations, financial flexibility may be constrained, and unexpected costs could pose challenges.